{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:57:16Z","timestamp":1780991836489,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,1,6]],"date-time":"2015-01-06T00:00:00Z","timestamp":1420502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s12028-014-0102-9","type":"journal-article","created":{"date-parts":[[2015,1,5]],"date-time":"2015-01-05T21:59:31Z","timestamp":1420495171000},"page":"429-436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Metronidazole-Induced Encephalopathy: Not Always a Reversible Situation"],"prefix":"10.1007","volume":"22","author":[{"given":"Kyle","family":"Hobbs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Stern-Nezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion S.","family":"Buckwalter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Fischbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Finley Caulfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,6]]},"reference":[{"key":"102_CR1","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2165\/00003495-199754050-00003","volume":"54","author":"CD Freeman","year":"1997","unstructured":"Freeman CD, Klutman NE, Lamp KC. Metronidazole: a therapeutic review and update. Drugs. 1997;54:679\u2013708.","journal-title":"Drugs"},{"key":"102_CR2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00003088-199936050-00004","volume":"36","author":"KC Lamp","year":"1999","unstructured":"Lamp KC, Freeman CD, Klutman NE, Lacy MK. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials. Clin Pharmacokinet. 1999;36:353\u201373.","journal-title":"Clin Pharmacokinet"},{"key":"102_CR3","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/bmj.2.6087.610","volume":"2","author":"WG Bradley","year":"1977","unstructured":"Bradley WG, Karlsson IJ, Rassol CG. Metronidazole neuropathy. BMJ. 1977;2:610\u20131.","journal-title":"BMJ"},{"key":"102_CR4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4103\/0028-3886.76882","volume":"59","author":"KI Park","year":"2011","unstructured":"Park KI, Chung JM, Kim JY. Metronidazole neurotoxicity: sequential neuroaxis involvement. Neurol India. 2011;59:104\u20137.","journal-title":"Neurol India"},{"key":"102_CR5","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.ijid.2008.03.006","volume":"12","author":"K Patel","year":"2008","unstructured":"Patel K, Green-Hopkins I, Lu S, Tunkel AR. Cerebellar ataxia following prolonged use of metronidazole: case report and literature review. Int J Infect Dis. 2008;12:e111\u20134.","journal-title":"Int J Infect Dis"},{"key":"102_CR6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/WNF.0b013e3182334b35","volume":"34","author":"A Kuriyama","year":"2011","unstructured":"Kuriyama A, Jackson JL, Doi A, Kamiya T. Metronidazole-induced central nervous system toxicity: a systematic review. Clin Neuropharm. 2011;34:241\u20137.","journal-title":"Clin Neuropharm"},{"key":"102_CR7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/0091270010362905","volume":"51","author":"MM Bottenberg","year":"2011","unstructured":"Bottenberg MM, Hegge KA, Eastman DK, Kumar R. Metronidazole-induced encephalopathy: a report and review of the literature. J Clin Pharmacol. 2011;51:112\u20136.","journal-title":"J Clin Pharmacol"},{"key":"102_CR8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1212\/WNL.45.3.588","volume":"45","author":"A Ahmed","year":"1995","unstructured":"Ahmed A, Loes DJ, Bressler EL. Reversible magnetic resonance imaging findings in metronidazole-induced encephalopathy. Neurology. 1995;45:588\u20139.","journal-title":"Neurology"},{"key":"102_CR9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJM200201033460117","volume":"346","author":"BK Woodruff","year":"2002","unstructured":"Woodruff BK, Wijdick EF, Marshall WF. Reversible metronidazole-induced lesions of the cerebellar dentate nuclei. N Engl J Med. 2002;346:68\u20139.","journal-title":"N Engl J Med"},{"key":"102_CR10","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/00004728-200211000-00016","volume":"26","author":"KM Cecil","year":"2002","unstructured":"Cecil KM, Halsted MJ, Schapiro M, Dinopoulos A, Jones BV. Reversible MR imaging and MR spectroscopy abnormalities in association with metronidazole therapy. J Comput Assist Tomogr. 2002;26:948\u201351.","journal-title":"J Comput Assist Tomogr"},{"key":"102_CR11","first-page":"1615","volume":"24","author":"CJ Heaney","year":"2003","unstructured":"Heaney CJ, Campeau NG, Lindell EP. MR imaging and diffusion-weighted imaging changes in metronidazole (Flagyl)-induced cerebellar toxicity. Am J Neuroradiol. 2003;24:1615\u20137.","journal-title":"Am J Neuroradiol"},{"key":"102_CR12","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1001\/archneur.60.12.1796","volume":"60","author":"JM Seok","year":"2003","unstructured":"Seok JM, Yi H, Song YM, Lee WY. Metronidazole-induced encephalopathy and inferior olivary hypertrophy. Arch Neurol. 2003;60:1796\u2013800.","journal-title":"Arch Neurol"},{"key":"102_CR13","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3174\/ajnr.A0655","volume":"28","author":"E Kim","year":"2007","unstructured":"Kim E, Na DG, Kim JH, et al. MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings. Am J Neuroradiol. 2007;28:1652\u20138.","journal-title":"Am J Neuroradiol"},{"key":"102_CR14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neurad.2007.01.127","volume":"34","author":"N Hammami","year":"2007","unstructured":"Hammami N, Drissi C, Sebai R, et al. Reversible metronidazole-induced encephalopathy. J Neuroradiol. 2007;34:133\u20136.","journal-title":"J Neuroradiol"},{"key":"102_CR15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1212\/01.wnl.0000242579.37851.26","volume":"68","author":"JL Bonkowsky","year":"2007","unstructured":"Bonkowsky JL, Sondrup C, Benedict SL. Acute reversible cerebellar lesions associated with metronidazole therapy. Neurology. 2007;68:180.","journal-title":"Neurology"},{"key":"102_CR16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/RCT.0b013e31817e6f58","volume":"33","author":"SS Lee","year":"2009","unstructured":"Lee SS, Cha S, Lee SY, Chang JS. Reversible inferior colliculus lesion in metronidazole-induced encephalopathy: magnetic resonance findings on diffusion-weighted and fluid attenuated inversion recovery imaging. J Comput Assist Tomogr. 2009;33:305\u20138.","journal-title":"J Comput Assist Tomogr"},{"key":"102_CR17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3340\/jkns.2012.52.3.273","volume":"52","author":"HJ Jang","year":"2012","unstructured":"Jang HJ, Sim SY, Lee JY, Bang JH. Atypical metronidazole-induced encephalopathy in anaerobic brain abscess. J Korean Neurosurg Soc. 2012;52:273\u20136.","journal-title":"J Korean Neurosurg Soc"},{"key":"102_CR18","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1212\/WNL.0b013e3182918cf2","volume":"80","author":"SE Erdener","year":"2013","unstructured":"Erdener SE, Kansu T, Arsava EM, Dericioglu N. Brain MRI evolution of metronidazole intoxication. Neurology. 2013;80:1816\u20137.","journal-title":"Neurology"},{"key":"102_CR19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jns.2004.06.012","volume":"224","author":"DW Kim","year":"2004","unstructured":"Kim DW, Park J, Yoon B, et al. Metronidazole-induced encephalopathy. J Neurol Sci. 2004;224:107\u201311.","journal-title":"J Neurol Sci"},{"key":"102_CR20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3350\/kjhep.2011.17.2.157","volume":"17","author":"HC Cheong","year":"2011","unstructured":"Cheong HC, Jeong TG, Cho YB, et al. Metronidazole-induced encephalopathy in a patient with liver cirrhosis. Korean J Hepatol. 2011;17:157\u201360.","journal-title":"Korean J Hepatol"},{"key":"102_CR21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clinthera.2010.01.018","volume":"32","author":"MV Groothoff","year":"2010","unstructured":"Groothoff MV, Hofmeijer J, Sikma MA, Meulenbelt J. Irreversible encephalopathy after treatment with high dose intravenous metronidazole. Clin Ther. 2010;32:60\u20134.","journal-title":"Clin Ther"},{"key":"102_CR22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7326\/0003-4819-88-3-361","volume":"88","author":"S Frytak","year":"1978","unstructured":"Frytak S, Moertel CG, Childs DS, Albers JW. Neurologic toxicity associated with high-dose metronidazole therapy. Ann Intern Med. 1978;88:361\u20132.","journal-title":"Ann Intern Med"},{"key":"102_CR23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF00686856","volume":"25","author":"P Rogulja von","year":"1973","unstructured":"von Rogulja P, Kovac W, Schmid H. Metronidazole encephalopathy der Ratte. Acta Neuropathol (Berl). 1973;25:36\u201345.","journal-title":"Acta Neuropathol (Berl)"},{"key":"102_CR24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2214\/AJR.07.3959","volume":"192","author":"G Zuccoli","year":"2009","unstructured":"Zuccoli G, Pipitone N. Neuroimaging findings in acute Wernicke\u2019s encephalopathy: review of the literature. AJR. 2009;192:501\u20138.","journal-title":"AJR"},{"key":"102_CR25","doi-asserted-by":"crossref","first-page":"E84","DOI":"10.3174\/ajnr.A1142","volume":"29","author":"G Zuccoli","year":"2008","unstructured":"Zuccoli G, Pipitone N. Metronidazole-induced encephalopathy and Wernicke\u2019s encephalopathy: two different entities sharing the same metabolic pathway? Am J Neurorad. 2008;29:E84.","journal-title":"Am J Neurorad"},{"key":"102_CR26","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3174\/ajnr.A2979","volume":"33","author":"ND Ha","year":"2012","unstructured":"Ha ND, Weon YC, Jang JC, Kang BS, Choi SH. Spectrum of MR imaging findings in Wernicke encephalopathy: are atypical areas of involvement only present in nonalcoholic patients? Am J Neurorad. 2012;33:1398\u2013402.","journal-title":"Am J Neurorad"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-014-0102-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12028-014-0102-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-014-0102-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:14:42Z","timestamp":1559441682000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12028-014-0102-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,6]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["102"],"URL":"https:\/\/doi.org\/10.1007\/s12028-014-0102-9","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,6]]}}}